NattoPharma enters Chinese market with new MenaQ7 launch

d5bdeb08-e8a9-4ece-b0d7-f0d4ed738c68articleimage.jpg

30 Nov 2017 --- NattoPharma has participated in a launching conference commemorating the first product introduced in China featuring MenaQ7 Vitamin K2 as MK-7. During the event, FishBurg, a Chinese dietary supplement producer in the calcium/vitamin D3 (VD3) segment, signed a partnership and supply agreement with NattoPharma and officially launched its new Blue Hat-registered calcium/VD3/MenaQ7 Vitamin K2 supplement for bone health to the Chinese market.

The event was attended by 150 distributors from all across China who will promote the new FishBurg product via pharmacies and other Chinese dietary supplement channels. During the event, FishBurg, NattoPharma and the Norwegian council made presentations that marked the start of the important partnership and entry into the Chinese market.

The event culminated with the signing of the strategic partnership and supply agreement between FishBurg and NattoPharma. There was then a ribbon-cutting ceremony.

“With a population of 1.4 billion – particularly with the middle class somewhere in the neighborhood of 400 million – China represents significant market opportunity,” Daniel Rosenbaum, CEO of NattoPharma, tells NutritionInsight. “The importance of bone and cardiovascular health is a global concern, and a growing concern in China. As awareness of how Vitamin K2, and specifically MenaQ7 Vitamin K2 as MK-7, increases, it is clear we can play an important role in improving health of Chinese people.”

“The product launch is a clear indication of the commitment from both parties,” says Rosenbaum. “The event created excitement around MenaQ7 Vitamin K2, which has amazing market potential in China.”

Addressing the Chinese market’s challenges, Rosenbaum notes that NattoPharma is not competing directly with Chinese Medicine (TCM): “There is a long tradition of alternative therapies, including supplements and TCM, to improve health and wellness, so we see our efforts as complementary.”

“There is a fairly rigorous registration process in China, so as a company with strong clinical foundation for our high-quality material, this helps to distinguish us in the Chinese market,” Rosenbaum adds. “For example, it was clear with the FishBurg launch that our clinical data and continued commitment to clinical research were important factors for this outstanding company choosing us as their partner.”

The launch event was hosted by NattoPharma’s Chinese distributor partner Prochin, one of the first foreign enterprises set up in the Shanghai Free Trade Zone, focused on Food Ingredients, and one of China’s importers of dairy-based specialty ingredients. According to Jordan Yang, the commercial director of Prochin, distributors were excited to learn about MenaQ7’s arrival in China.

“FishBurg is quite confident that the newly launched calcium/VD3/MenaQ7 Vitamin K2 product will have a very impressive impact on the Chinese nutritional market, bringing the benefits of bone and cardiovascular health to all customers,” says Youwen Chen, the CEO of FishBurg.

“Not only does NattoPharma actively engage the media to help spread the word about the benefits of Vitamin K2, but we work hand-in-hand with our partners to help educate their specific markets and customers” Rosenberg adds. “For example, our Chief Medical Officer has just completed a tour through different countries in southeast Asia talking to practitioners and brand owners.”

In other recent news about NattoPharma’s MenaQ7 Vitamin K2, researchers have discovered that it could be a novel therapeutic target for calcific aortic valve stenosis (CAVS). NattoPharma has also successfully secured patents in Israel, the US and Australia for its “nature-identical synthesis” creating MenaQ7 PharmaPure Vitamin K2 as MK-7, adding further to the company’s patent portfolio.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Navigating the digestive health space: Probiotic strain specificity and microbiome key to future NPD

16 Nov 2018 --- Emerging science linking a healthy microbiome to nearly every facet of health, as well as the ongoing media reporting on probiotics, have helped drive consumer interest in gut health. This growing area offers a wealth of opportunities to formulators, but due to regulatory demands and increasing consumer scrutiny, a clear view of how to navigate this space is vital.

Health & Nutrition News

Supplement use in China could ease the double burden of malnutrition, researchers note

14 Nov 2018 --- Despite the Chinese population displaying deficiencies in some key nutrients, such as vitamin B2 and calcium, research has shown that the use of nutritional supplements is relatively low. The involved researchers suggest that adequate supplementation could help to ease the double burden of malnutrition facing the country. 

Health & Nutrition News

Yuzu, taro and cookie dough: Innovative flavors flex their muscles in sports nutrition category 

12 Nov 2018 --- The sports nutrition market is continually undergoing growth, necessitating flavor innovation for both product differentiation and base-protein taste masking. In an era of bountiful choice, it has never been more critical, yet challenging, to stand out on the shelf, and one way to catch a consumers eye is through novel flavor use. “Flavours of the future” in the sports nutrition market span global cuisines to tantalize future consumer taste buds with yuzu and mochi flavors, as well as US-style s’mores, cookie dough and birthday cake, according to a research project conducted by Synergy Flavours. 

Health & Nutrition News

Weekly Roundup: CJ CheilJedang expands Indonesia plant, Valensa hosts expert panel on saw palmetto

09 Nov 2018 --- This week in nutrition, CJ CheilJedang has expanded its Indonesia Jombang plant with a new production line, while Advanced Organic Materials is expanding its manufacturing operations into Spain. OmniActive Health Technologies CurcuWIN and Lutemax 2020 both gained US Pharmacopeia (USP) verification, and Valensa International appointed Sendhil Pani to lead its microalgae market expansion. Valensa also hosted an expert panel yesterday to examine the damage to saw palmetto extract’s sustainability following recent hurricane damage in the Florida area.

Health & Nutrition News

Conveying overall wellness: Better-for-you NPD thrives on protein, fiber and natural platforms

08 Nov 2018 --- With half of all food and beverage launches in 2018 year to date having a better-for-you claim, the surge in product innovation catering to consumer demands for a healthier lifestyle is clear-cut. But what are some of the standout strategies for creating products with a much sought after health halo? Yesterday’s webinar presented by Innova Market Insights cast a light on the role of protein, fiber and natural ingredients in providing formulators with key strategies to convey overall wellness in food and beverage development.

More Articles
URL : http://www.nutritioninsight.com:80/news/nattopharma-enters-chinese-market-with-new-menaq7-launch.html